Clinical Trial Update: Melatonin for Prevention of Kidney Injury [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Rutgers is evaluating whether melatonin can prevent acute kidney injury in at-risk patients; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Acute Kidney Injury, Adverse Drug Event | Phase 3 | Status: RECRUITING